Detalhe da pesquisa
1.
The pseudo-caspase FLIP(L) regulates cell fate following p53 activation.
Proc Natl Acad Sci U S A
; 117(30): 17808-17819, 2020 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32661168
2.
A first-in-human Phase I dose-escalation trial of the novel therapeutic peptide, ALM201, demonstrates a favourable safety profile in unselected patients with ovarian cancer and other advanced solid tumours.
Br J Cancer
; 127(1): 92-101, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35568736
3.
A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424.
Br J Cancer
; 118(6): 770-776, 2018 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438361
4.
Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival.
Mod Pathol
; 30(9): 1287-1298, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28621318
5.
A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301).
J Exp Clin Cancer Res
; 43(1): 100, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38566164
6.
Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients.
Eur J Cancer
; 188: 29-38, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37182343
7.
Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer.
Mol Cancer Ther
; 20(9): 1627-1639, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34389694
8.
Clinical determinants of response to irinotecan-based therapy derived from cell line models.
Clin Cancer Res
; 14(20): 6647-55, 2008 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18927307
9.
Predicting the outcome of chemotherapy for colorectal cancer.
Curr Opin Pharmacol
; 6(4): 332-6, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16750422
10.
Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer.
Curr Colorectal Cancer Rep
; 12: 141-150, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27340376
11.
Metastatic melanoma: a regional review and future directions.
Tumori
; 98(5): 575-80, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23235751
12.
Pharmacogenomic profiling and pathway analyses identify MAPK-dependent migration as an acute response to SN38 in p53 null and p53-mutant colorectal cancer cells.
Mol Cancer Ther
; 11(8): 1724-34, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22665525
13.
A systems biology approach identifies SART1 as a novel determinant of both 5-fluorouracil and SN38 drug resistance in colorectal cancer.
Mol Cancer Ther
; 11(1): 119-31, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22027693
14.
Genomic markers for decision making: what is preventing us from using markers?
Nat Rev Clin Oncol
; 7(2): 90-7, 2010 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-20010899
15.
Re: test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.
J Natl Cancer Inst
; 107(5)2015 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25758031
16.
Predictive and prognostic markers in colorectal cancer.
Per Med
; 4(3): 295-306, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29788671
17.
Genomic profiling of colorectal cancer.
Eur J Cancer
; 45 Suppl 1: 371-4, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19775635